IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Par Drugs and Chemicals IPO listing price is ₹ 51.45, issue price is ₹ 51.00, and currently trading at ₹ 98.00 as on June 12, 2025. Par Drugs and Chemicals IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Par Drugs and Chemicals IPO is a Fixed Price listing on NSE EMERGE exchange. The company is based in Vadodara and caters to Pharmaceutical sector. Pantomath Capital Advisors is the merchant banker of Par Drugs and Chemicals IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 29th March 2019.
Par Drugs and Chemicals IPO offer price is ₹ 51.00 and got listed at ₹ 51.45. Read Par Drugs and Chemicals IPO details mentioned above.The IPO of Par Drugs and Chemicals Limited was listed on 16th May 2019. As of today, Par Drugs and Chemicals IPO is trading at ₹ 98.00, compared to the previous day’s close of ₹ 98.80. Read the report above for detailed IPO performance.
The issue price of Par Drugs and Chemicals IPO was ₹ 51.00 per equity share.
Par Drugs and Chemicals IPO was listed at ₹51.45 on the stock exchange on 16th May 2019. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of June 12, 2025, the current market price of Par Drugs and Chemicals IPO is ₹ 98.00.
The 52-week high for Par Drugs and Chemicals IPO is ₹ 348.45, while the 52-week low is ₹ 81.01. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Par Drugs and Chemicals IPO listed at ₹ 51.45 against the issue price of ₹ 51.00 per equity share, showing a listing day gain/loss of 0.45 (0.88%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Par Drugs and Chemicals IPO stock moved from its listing price of ₹ 51.45 to the current price of ₹98.00 per equity share, reflecting a change of 90.48% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Par Drugs and Chemicals IPO issue date of 16th May 2019 and CMP of ₹98.00, the estimated CAGR is approximately 11.32%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
₹ 51.00
Listing Price :
₹ 51.45
Previous Day Closing
₹ 98.80
Par Drugs and Chemicals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Par Drugs and Chemicals Financial Review Page
Merchant Banker(s) of Par Drugs and Chemicals IPO: Pantomath Capital Advisors Private Limited
Par Drugs and Chemicals IPO subscription was 5.74 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Par Drugs and Chemicals IPO listed at a listing price of 51.45 against the offer price of 51.00.
The current market price of Par Drugs and Chemicals is 98.00.
Why Us?
